Activation and elevation of PPARα and PPARδ expression is known to increase expression of CPT1, ACO and UCP3 to elevate energy expenditure, subsequently resulting in anti-obesity actions [37–40]. Here, KLK15 is linked to obesity due to melanocortin 4 receptor deficiency.